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ABSTRACT
Mathematically, the human alimentary tract organs were simplified in the model structure as separate compartments with 
pathways of transfer that are kinetically homogenous and equally distributed. The development of gastro-compartment 
model follows the first order kinetics of differential equations to describe cadmium absorption, distribution and elimination 
in the human digestive system. With the aid of in vitro DIN assay, an artificial gastric and gastrointestinal fluid were 
prepared using water leach purification (WLP) residue as a sample that contained toxic metals cadmium. The Simulation, 
Analysis and Modelling II (SAAM II) V2.1 software is employed to design models easily, simulate experiments quickly and 
analyze data accurately. Based on the experimental inputs and fractional transfer rates parameter incorporated to the 
gastro-compartment model, the concentration of cadmium against time profile curves were plotted as the model output. 
The curve presented concentration of cadmium in both gastric and gastrointestinal fluid where initially absorption phase 
(first hour) occurred followed by the distribution phase (second to third hours) and elimination process (third to fifth 
hours). The concentration of cadmium obtained from the simulated model structures was in good agreement with the 
fitted model predicted measurements as statistical t-test conducted showed the values were not significantly different. 
Therefore, modeling approach with SAAM II software gave realistic and better estimation of cadmium dissolution into 
the human gastrointestinal tract.
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ABSTRAK
Dengan kaedah matematik, organ saluran pencernaan manusia boleh dipermudahkan dengan menggunakan struktur 
model sebagai ruang berasingan dilengkapi dengan laluan pemindahan yang bersifat homogen dan diedarkan secara 
sama rata. Pembangunan model gastro-ruang dibina dengan kaedah persamaan pembezaan kinetik tertib pertama bagi 
menghuraikan proses penyerapan kadmium, pengedaran dan perkumuhan dalam sistem pencernaan manusia. Dengan 
bantuan teknik cerakin in vitro DIN, cecair gastrik dan gastrousus tiruan telah disediakan menggunakan sisa pemurnian 
larut lesap air (WLP) sebagai sampel yang mengandungi logam bertoksik kadmium. Perisian Simulasi, Analisis dan 
Pemodelan II (SAAM II) V2.1 digunakan bagi mereka bentuk model dengan lebih mudah, mensimulasi uji kaji dengan 
cepat dan menganalisis data secara tepat. Berdasarkan input uji kaji dan parameter kadar pemindahan pecahan yang 
dimasukkan ke dalam model gastro-ruang, lengkungan kepekatan kadmium terhadap profil masa telah dilakarkan 
sebagai output model. Lengkungan menunjukkan kepekatan kadmium dalam kedua-dua cecair gastrik dan gastrousus 
dimulai dengan fasa penyerapan (jam pertama) dan diikuti dengan proses pengedaran (jam kedua hingga ketiga) dan 
perkumuhan (jam ketiga hingga kelima). Kepekatan kadmium yang diperoleh daripada struktur model simulasi adalah 
selari dengan lengkungan suaian model anggaran dengan ujian statistik t-test yang dijalankan menunjukkan nilai tersebut 
tidak mempunyai perbezaan yang signifikan. Oleh itu, pendekatan pemodelan dengan perisian SAAM II dapat memberikan 
anggaran yang realistik dan lebih baik bagi proses pelarutan kadmium ke dalam saluran penghadaman manusia.
Kata kunci: in vitro DIN; kadmium; kompartmen; model; SAAM II
INTRODUCTION
Since 1979, the International Commission on Radiological 
Protection (ICRP) has developed the gastrointestinal tract 
model that has been used to describe the transport and 
kinetic behavior of heavy metals throughout the human 
body (ICRP 1989). Mathematically, all the human organs 
and tissues are represented with separate compartments 
with each of them connected via fractional transfer rates. 
In general, modeling plays vital role to analyze dynamic 
systems of the human body in relation to transfer of 
substances as it undergoes absorption, distribution and 
excretion in the biological systems (Kjeldsen & Ottesen 
2014). Simulation, Analysis and Modelling II (SAAM II) 
Version 2.1 software was developed by the University 
of Washington, Seattle in aid for kinetic analysis as 
well as to empower understanding of physiology and 
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pathophysiology (Clifford & Muller 1998). Several other 
purposes include the identification of the system structure, 
estimation of immeasureable quantities, prediction of 
physiologic variables and diagnosis to improve reliability 
and accuracy of the system studied (Bronzino 2000). 
Compartment models are created based on the differential 
equations incorporated to the model structures which 
are unique for every system studied. Thus, a complex 
physiologic system can be viewed as a finite number of 
compartments with pathways that are well mixed and 
homogenous (Clifford & Muller 1998). 
 The exposure of cadmium in the environment has 
long been recognized as health hazards due to its tendency 
to concentrate in critical organs such as bone and liver 
that bound to metallothionein, a sulfur-rich intracellular 
protein (Akesson et al. 2014). Cadmium is a trace element 
from Group 12 that is known as an ecotoxic metals that 
exhibit adverse impacts to the environment and the 
quality of food (Kabata-Pendias & Mukherjee 2013). 
Cadmium existed naturally in the range of 0.1 - 0.5 ppm 
concentrations in the earth crust. The soluble forms of 
cadmium can be transported to surface and groundwater 
whereas the unsoluble forms remained to sediment as a 
result of adsorption process (ATSDR 2012). Meanwhile 
during weathering process, cadmium tends to form mobile 
compunds such as Cd(OH)2, CdCl2, CdO and CdF2. The 
emission of cadmium either in the particulate forms or 
leachate will expose humans via food chains, inhalation, 
skin wound and direct contact with contaminated soils. 
The toxicity impact may be acute or chronic depends on 
the amount of cadmium ingested and accumulated in the 
biological tissues (ATSDR 2012).
 The absorption efficiency of cadmium depends on 
the solubility behaviour, exposure concentration and route 
of the cadmium compounds. Based on previous study of 
(Goyer 1991), cadmium deposition has been estimated to 
be 50 to 70% in the kidneys and livers. The contents of 
cadmium in soft tissues of humans range from 0.03 to 14 
mg kg–1, being the highest in kidneys and lowest in the 
muscles. Concurrently, the average content of cadmium for 
the ‘reference man’ is 0.17 mg kg–1. The estimated intake 
of Cd in the diet is 20-50 μg d-1 where it may retained in 
the body for a relatively long time up to 30 years (Kabata-
Pendias & Mukherjee 2013).
 In this study, a gastro-compartment model was 
developed to simulate the oral intake of cadmium 
released from water leach purification (WLP) residue 
samples with the aid of in vitro DIN assay; to compare 
concentrations obtained between experimental and 
predicted measurements; and to deepen understanding of 
cadmium absorption, distribution and elimination into the 
gastrointestinal tract using mathematical model SAAM II 
approach. 
MATERIALS AND METHODS
SAMPLE PREPARATION
Water leach purification (WLP) residue samples were 
collected from Lynas Advanced Materials Plant (LAMP), 
Gebeng Industrial Estate (GIE), Kuantan, Pahang with the 
Global Positioning System (GPS) coordinate of E 103º 
22’ 34”, N 4º 0’ 21” as shown in Figure 1. The samples 
were kept in the clean polyvinyl plastic container during 
transportation to avoid any contamination. The samples 
were oven dried at 80ºC for 24 h, grounded with a 
mortar and sieved with 0.5 mm mesh siever to produce a 
homogenized samples (Al-areqi 2014; Mohd et al. 2017).
FIGURE 1. Location of sampling area in Gebeng Industrial Estate (GIE), 
Kuantan, Pahang, Malaysia
k0i
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ANALYTICAL PROCEDURE
WLP residue samples collected from the study area 
were analyzed with Wavelength Dispersive X-ray 
Fluorescence (WDXRF) and Inductively Coupled Plasma 
Mass Spectrometer (ICP-MS) for both prior and after 
digestion of samples, respectively. To obtain the total 
concentrations of cadmium contained in WLP, the residue 
samples were sent to analyze using Bruker S8 Tiger at 
Centre for Research and Instrumentation (CRIM), Universiti 
Kebangsaan Malaysia (UKM). The result obtained was 
used to represent the input data incorporated to the 
gastrointestinal tract compartmental model (Clifford & 
Muller 1998). A reference standard soil International 
Atomic Energy Agency (IAEA 2004) - 7 was employed to 
ensure the accuracy of the analytical instrument (Pszonicki 
et al. 2000). Subsequently, the samples and blank solution 
were digested for further analysis using ICP-MS Perkin 
Elmer ELAN 6000 at Malaysian Nuclear Agency (MNA). 
The National Institute of Standards and Technology 
(NIST), United States (US) standard reference material was 
included for quality assurance (QA) and quality control (QC) 
of the instrument measurements (Kamunda et al. 2016). 
The samples were digested via in vitro Deutsches Institut 
für Normung (DIN) (Höllriegl et al. 2010), respectively, 
depending on the digestion method. Subsequently, the 
committed effective doses from intake of (238; Mohd et al. 
2017). The assay was developed by the German Institute to 
aid in digestion of samples that resemble human digestive 
system. The samples were digested to produce both gastric 
and gastrointestinal fluids. 
GASTRIC PHASE
About 2.0 g of WLP residue samples were mixed with 0.29 
g NaCl, 0.07 g KCl, 0.027 g KH2PO4, 0.1 g pepsin, 0.3 
g mucin, and HCl (30%) to form synthetic gastric fluids. 
The samples were prepared in triplicate with solid to 
liquid ratio of 1:50. The mixed solutions were subjected 
for 2 h of incubation with pH of 2.0 ± 0.3 that follows the 
human residence time (1-3 h) and pH of the stomach (pH 
1.5 - 4). The temperature of the water bath used throughout 
the incubation phase was maintained at 37ºC to simulate 
normal human body temperature. After incubation ended, 
the gastric fluids were extracted (10 mL) and centrifuged 
at 3500 rpm for 15 min. Finally, the gastric fluids were 
filtrated with 0.45 μm filter paper using Rocker 400 
laboratory vacuum gas pump. The filtrated synthetic gastric 
fluids were analyzed for 5 h of interval time with ICP-MS 
(Höllriegl et al. 2010), respectively depending on the 
digestion method. Subsequently, the committed effective 
doses from intake of (238; Mohd et al. 2017; Rashid et al. 
2015; Wragg & Cave 2002).
GASTROINTESTINAL PHASE
The gastrointestinal assay was prepared by mixing the 
remaining volume of the synthetic gastric fluids with 0.03 
g KCl, 0.05 g CaCl2 × 2H2O, 0.02 g MgCl2 × 6H2O, 0.03 g 
trypsin, 0.9 g pancreatin, 0.9 g bile bovine, 0.03 g urea and 
NaHCO3 solid (solid to liquid ratio 1:100). The synthetic 
gastrointestinal fluids prepared were incubated for 6 h 
with pH of 7.5 ± 0.3 and 37ºC of water bath temperature. 
The normal human residence time for intestinal digestion 
is 1 - 6 h with pH 5.5 - 7.5 (Versantvoort et al. 2004). 
About 10 mL of the fluids were extracted and subjected 
for centrifugation at 3500 rpm for 15 min. These process 
were followed by the filtration process of gastrointestinal 
fluids before further analysis with ICP-MS (Höllriegl et al. 
2010), respectively,  depending on the digestion method. 
Subsequently, the committed effective doses from intake 
of (238; Mohd et al. 2017; Rashid et al. 2015; Wragg & 
Cave 2002).
BIOKINETIC MODEL DEVELOPMENT
An integrated software of SAAM II was employed to 
construct and develop gastrointestinal tract compartment 
model that is used to describe the kinetic dissolution 
of cadmium from WLP residue samples in the human 
digestive system. The model in Figure 2 described the ith 
compartment of an n-compartment model and the general 
(1) used to express the compartmental model is as follows 
(Bronzino 2000).
 qi = �j≠i kij – �j≠i kji – k0i + ui  (1)
where qi is the ith compartment; ui is the exogenous input; 
kij is the fractional transfer rates from compartment j to I; 
kji is the fractional transfer rates from compartment i to j; 
k0i is the fractional loss rates from compartment i.
FIGURE 2. The basic ith compartment model development with 
fractional transfer of flow in and out of the compartment and 
exogenous input incorporation where qi is the ith compartment, 
ui is the exogenous input, kij is the fractional transfer rates 
from compartment j to i, kji is the fractional transfer rates from 
compartment i to j and k0i is the fractional loss 
rates from compartment i
 Based on ICRP Pub 30, four compartments with 
default transference coefficient (λ) that involved following 
ingestion were stomach (24 d-1), small intestine (6 d-1), 
upper large intestine (1.8 d-1) and lower large intestine (1 
d-1), respectively as presented in Figure 3 (ICRP 1997). 
 Meanwhile, the transfer of cadmium from small 
intestine to blood plasma take account f1 factor as the 
fraction of cadmium that is absorbed to the blood plasma 
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directly without passing through other regions of the 
humans digestive tract system. The f1 (gut transit factor) 
for cadmium was 0.05 (Eckerman et al. 1988). The 
transference coefficient for cadmum from small intestine 
to blood plasma can be calculated using (2) given based 
on the ICRP guidelines.
 Small Intestine to Blood Plasma Transference 
Coefficient, λB
      
  (2)
where f1 is the gut transfer factor; and λSI is the transference 
coefficient of small intestine (day).
 Once absorbed, cadmium is distributed to several 
organs including 30% to liver (tb1/2 of 19 years) and kidneys 
(tb1/2 of 38 years) and 0.01% excreted through urine (tb1/2 of 7 
days). The fractional transfer rates for k1, k2 and k3 denoted 
for liver, kidney and urinary excretion, respectively can be 
derived using Equation 3 (Li et al. 2005). 
Fractional Transfer Rates, kx
  (3)
where a is the amount of materials transferred to the 
compartment; and tb1/2 is the biological half-time (day).
 The model structures were constructed according 
to the experimental study where the samples s1, s2, 
s3 represent cadmium concentration in the gastric 
fluids whereas samples s4, s5, s6 represent cadmium 
concentration in the gastrointestinal fluids. The transfer 
coefficient parameter, k(i,j) is denoted by arrow connecting 
each compartments to enact as the fraction of substances 
transferred from compartment j to compartment i per 
unit time (SAAM II 2011). To simulate the experimental 
study, an exogenous input (ex1) was introduced to stand 
for the amount of instantenous input that occured at the 
specified time. The equation for sampled value s1 = q1/
vol that refer to the total amount of tracer divided with the 
volume of the compartment was formed. To allow the use 
of prior knowledge related to the fractional transfer rates of 
cadmium for ingestion model, Bayesian estimation option 
was selected (Redeker & Blust 2004). The compartmental 
model was adjusted based on the differential equations 
until predictions and experimental measurements agree 
and provide a statistical criterion of goodness of fit and 
model adequacy.
RESULTS AND DISCUSSION
In this model, cadmium is introduced as an oral bolus input 
to the mouth compartment that acts as the first compartment 
following ingestion. The ex1 for cadmium was 0.75 mg 
kg-1 that was obtained via WDXRF analysis as the total 
concentration of cadmium contained in the WLP residue 
samples. Simultaneously, the sample data obtained from 
the ICPMS analysis for digested cadmium was introduced 
to the corresponding compartments of q1 (stomach) and 
q2 (small intestine), respectively. As shown in Figure 
4, eight gastro-compartments (q1 – q8) were modeled 
to describe the cadmium absorption, distribution and 
elimination in the human alimentary tract. The absorption 
mainly occurs in q2 (small intestine) compartment to q5 
(blood plasma) compartment, distribution in q5 (blood 
plasma) compartment to q6 (liver) compartment and q7 
(kidney) compartment and elimination involves q7 (kidney) 
compartment to urinary excretion.
 The transfer of cadmium between each compartments 
were characterized by the first-order kinetics expressed 
as  (NCRP 2006). The differential equations 
in Table 1 were created to describe the change in the 
amount of cadmium in the compartment over time for 
FIGURE 3. Biokinetic model to describe cadmium intake into the gastroinestinal tract recommended by 
ICRP Pub 30 (IAEA 2004; ICRP 1997; Li et al. 2005) 
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each compartments. Simultaneously, the flux transfer rate 
equations were created from the model to represent the 
fractions of cadmium contained in particular compartment 
that leaves the compartment in a unit of time.
 In compartmental modeling, oral administration of 
substances involve absorption, distribution and elimination 
processes as illustrated in Figure 5 (Gunaratna 2001). 
The absorption phase is mainly the initial process where 
the substances ingested are absorbed into the body 
through absorption site such as small intestine in the 
human gastrointestinal system. The substances distribute 
rapidly from the administration site into the systemic 
blood circulation. Meanwhile, the elimination process is 
irreversible where the removals of substances from the body 
occur (Gunaratna 2001).
 Following a successful fit of the model to the 
experimental data, a graphical concentration of cadmium 
for both gastric and gastrointestinal fluids was plotted as 
shown in Figure 6. The observed concentration values were 
denoted by the bullet while on the contrary the predicted 
outputs were represented by the dotted line against the time 
interval. The first curves shown were the absorption phase of 
TABLE 1. The model differential equations and flux transfer rates equations 
employed to describe each specified compartments for cadmium kinetic behavior in 
the gastrointestinal tract over unit of time
Compartment model differential equations Flux transfer rate equations
 = +k(7,5)  *q5 – k(0,7) *q7 flux (1,8) = k(1,8)  
*q8
 = +k(6,5)  *q5 flux (2,1) = k(2,1) 
*q1
 = +k(5,2)  *q2 – k(6,5) *q5 – k(7,5) *q5 flux (3,2) = k(3,2) 
*q2
 = +k(4,3) *q3 – k(0,4) *q4 flux (4,3) = k(4,3) 
*q3
 = +k(3,2)  *q2 – k(4,3) *q3 flux (5,2) = k(5,2) 
*q2
 = +k(2,1)  *q1 – k(3,2) *q2 – k(5,2) *q2 flux (6,5) = k(6,5) 
*q5
 = +k(1,8)  *q8 – k(2,1) *q1 flux (7,5) = k(7,5) 
*q5
 = –k(1,8)  *q8+ex1 flux (0,4) = k(0,4) 
*q4
flux (0,7) = k(0,7) *q7
FIGURE 4. Mathematical representation of eight gastro-compartment model (q1 - q8) constructed using SAAM II to 
illustrate pathways of cadmium intake into the gastrointestinal system where ex1 (exogenous input), ST (stomach), 
SI (small intestine), ULI (upper large intestine) and LLI (lower large intestine. The samples employed were s1, s2, s3 
(cadmium concentration in gastric phase) and s4, s5, s6 (cadmium concentration in gastrointestinal phase)
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the cadmium-concentration time profile. The curves plotted 
presented cadmium concentration in gastric fluid was much 
higher than the gastrointestinal fluid where the gastric acidity 
of the stomach affects the kinetic dissolution of cadmium 
(Calvey & Williams 2007). During the absorption phase, the 
rate of cadmium absorption was greater than the elimination 
rate. Some of the factors that affects the rate and extent of 
cadmium absorption are stomach-emptying rate, surface 
area of the GI tract and blood flow (Shargel et al. 2012). 
 The second phase involves the distribution phase which 
begins after the peak of the curves, maximum concentration 
(Cmax) curves at time interval of first hours (tmax). In this 
latter phase, ingested cadmium was equally distributed 
within the organs that were transported from the blood 
circulatory system. The Cmax for cadmium in the gastric 
fluid was 0.135 and 0.025 mg kg-1 for gastrointestinal fluid. 
Both maximum concentrations were much higher than the 
minimal risk level (MRL) for chronic duration of cadmium 
oral exposure (≥1 year) which was 4.17×10-6 mg kg-1 per 
h (0.0001 mg Cd/kg/day) (ATSDR 2012). Subsequently, the 
major portion of the cadmium distributed will accumulate 
in the liver and kidney for a relatively long time up to 30 
years. 
 The descending slope of the curves was dominated by 
the elimination phase that begins at third hours of the time 
interval. The absorption rate reaches zero (0) as the cadmium 
concentration reached the elimination phase (Vo 2017). The 
rate of excretion depends on the body burden and as renal 
dysfunction develops, the concentration of cadmium in the 
hepatic and renal will fall due to increased leakage of bound 
cadmium for urinary excretion (von Apeldoorn & Speijers 
2016). 
 Based on Table 2, the experimental design measured 
three concentration values of cadmium digested via in 
vitro DIN for 5 h of interval time. Meanwhile, the outputs 
of simulated model in SAAM II generated predicted 
concentration values corresponding to each observed 
concentration against the time interval. Based on t-test 
statistical analysis shown in Table 2, the cadmium 
concentration in gastric fluids resulted in p-value of 0.134 
whereas the cadmium concentration in gastrointestinal 
fluids has the outcome of p-value of 0.133. This showed 
FIGURE 5. Schematic representation of concentration-time curve for 
oral ingestion (Gunaratna 2001)
FIGURE 6. Concentration of cadmium (mg/kg) against time (hours) curves was plotted using SAAM II for comparison between 
observed gastric (GJ) and gastrointestinal juice (GIJ) concentration (bullet) in comparison to predicted concentration (line)
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cadmium concentration for both gastric and gastrointestinal 
phases were not significantly different between the observed 
and predicted values. The model constructed to simulate 
the intake of cadmium in the human digestive tract was in 
good agreement for both experimental and modelling output 
concentration.
CONCLUSION
The experimental data incorporated to the development 
of gastro-compartment model help in aid to simulate the 
intake of cadmium into the human digestive tract. The 
compartments specified with differential equations were 
solved numerically using SAAM II software where fitted 
model to the data was obtained. The concentration of 
cadmium against time curves obtained was characterized 
by initial slope for absorption phase (first hour), the 
distribution phase (second to third hours) following the 
maximum concentration peak and the elimination phase 
(third to fifth hours) in both gastric and gastrointestinal 
fluids. The statistical t-test performed showed that the 
values were not significantly different between the observed 
experimental data and predicted model measurements. 
Therefore, the simulated gastro-compartment model is 
in good agreement with the model output obtained that 
describe the kinetic process of absorption, distribution 
and elimination phases of cadmium incorporated into the 
human gastrointestinal system. 
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